President Donald Trump’s communications pause for HHS, FDA and other health-related agencies could push some drug approval decisions to later dates, a Raymond James analyst …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
Clinical trials around the world are developing new treatments in the hope of reducing non-small cell lung cancer cases. Image credit: Sebastian Kaulitzki Lung cancer
Lilly will gain worldwide rights for the development and commercialisation of DACRA molecules to treat obesity. Credit: New Africa/Shutterstock. Nordic Bioscience subsidiary KeyBioscience has announced
Merck’s 21-valent pneumococcal vaccine was approved by the FDA on Monday, bringing a new competitor to market for Pfizer’s 20-valent product. Merck’s vaccine, called Capvaxive